ISRCTN51663857已完成未知
Anticoagulation following tissue aortic valve replacement
St George's Healthcare NHS Trust (UK)0 个研究点目标入组 400 人开始时间: 2006年4月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Patients undergoing tissue aortic valve replacement
排除标准
- •1. Patients who require aspirin or warfarin therapy on established medical grounds
- •2. Patients unable to take warfarin or aspirin
研究者
相似试验
招募中
4 期
APT trialASaortic stenosisJPRN-jRCTs031220614Hayashida Kentaro360
进行中（未招募）
1 期
Preventing formation of blood clots due to atrial fibrillation, a cardiac arrhythmia that first occurred after coronary bypass surgery, with the help of anticoagulant medications.ew-Onset Post-Operative Atrial Fibrillation afterCABGMedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersEUCTR2021-005022-18-DEIcahn School of Medicine at Mount Sinai3,200
招募中
1 期
Preventing formation of blood clots due to atrial fibrillation, a cardiac arrhythmia that first occurred after coronary bypass surgery, with the help of anticoagulant medications.CTIS2024-515924-35-00Icahn School Of Medicine At Mount Sinai3,200
已完成
不适用
Observatory of Anticoagulation After Bioprosthetic Aortic Valve ReplacementAortic Valve DiseaseNCT01293188French Cardiology Society434
招募中
不适用
Surgical Replacement and Transcatheter Aortic Valve Implantation Trial 10 Year Follow-upsevere aortic valve stenosis10046973NL-OMON45149Medtronic B.V.160